Parco Chan

Parco Chan is a seasoned professional in market access and corporate strategy, currently serving as the Market Access Excellence Lead at Novo Nordisk since January 2025. Previously, Parco held the position of Corporate Strategy Director at Quibim from May 2023 to October 2024, focusing on artificial intelligence applications. Prior experience includes tenure at Eli Lilly and Company as Associate Manager of Pricing, where significant pricing strategies were developed amid business uncertainty, and at IQVIA as a Consultant in Real World Solutions, managing client engagements comprehensively. Early in the career, Parco was a Pharmacoeconomic Research Assistant at the MORE® Research Group. Academic credentials include an MBA from IMD and both a Master of Science and an Honours Bachelor of Science in Pharmacology from the University of Toronto.